In an era where digital transformation is reshaping every industry, healthcare and pharmaceuticals are no exception. One significant advancement is the electronic Product Information (ePI) initiative, based on the Fast Healthcare Interoperability Resources (FHIR) standard. This shift, led by the European Medicines Agency (EMA) and supported by regulatory networks, promises to bring accessible, real-time, and harmonized product information to healthcare providers and patients alike.
Electronic Product Information (ePI) is a structured, digital format of regulatory product information, including the Summary of Product Characteristics (SmPC), patient leaflets, and package labels. Developed using FHIR, an international standard for healthcare data exchange, ePI ensures that crucial medication details are accessible digitally across multiple platforms—web, mobile apps, and health systems. This means that patients and healthcare providers will always have access to the latest information at the point of need, enhancing both safety and efficiency.
1. Real-Time Updates: Unlike printed leaflets that can only be updated with new stock, ePI allows immediate updates to product information once approved. This capability ensures that everyone has access to the latest authorized information, helping to inform safer, more effective healthcare decisions.
2. Accessibility and Patient-Centered Care: ePI is designed with accessibility in mind, offering formats suitable for all users, including those with visual or other impairments. By supporting features like large print, high contrast, audio, and screen reader compatibility, ePI can meet the needs of diverse patients and empower them with accurate, up-to-date information.
3. Supporting Interoperability: Built on the FHIR standard, ePI can seamlessly integrate with electronic health records (EHRs), prescription systems, and other digital healthcare solutions. This interoperability is crucial in connecting healthcare data, reducing the risk of errors, and supporting better decision-making in patient care.
The EMA’s Implementation Guide provides technical details on how to structure and submit ePI information, using resources within the FHIR framework. This involves a structured process for pharmaceutical companies to create, manage, and distribute ePI across the EU, ensuring consistency in how information is delivered and accessed. With the adoption of the EU ePI Common Standard, ePI is not only becoming easier to manage but is also aligned with the latest regulatory and technological advancements.
Currently, ePI is most active in the European Union and the United States. As it gains traction, other regions are expected to adopt similar standards, enhancing global healthcare connectivity and streamlining regulatory compliance.
At ROPRA Life Sciences Institute, we are committed to guiding professionals and organizations through this significant transition. Our consulting services and training programs offer comprehensive support to help you understand and implement ePI FHIR labeling requirements effectively. From navigating regulatory standards to mastering technical details, we provide the knowledge and skills needed to ensure a smooth and compliant shift to digital labeling.
Join us at ROPRA and be prepared to lead in the future of electronic product information.
english
leave a Comment